Does PALBOCICLIB Cause Product administration interrupted? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product administration interrupted have been filed in association with PALBOCICLIB (Ibrance). This represents 0.0% of all adverse event reports for PALBOCICLIB.
17
Reports of Product administration interrupted with PALBOCICLIB
0.0%
of all PALBOCICLIB reports
3
Deaths
4
Hospitalizations
How Dangerous Is Product administration interrupted From PALBOCICLIB?
Of the 17 reports, 3 (17.6%) resulted in death, 4 (23.5%) required hospitalization.
Is Product administration interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Product administration interrupted?
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (1,446)
SODIUM OXYBATE (1,272)
CANNABIDIOL (511)
ISOTRETINOIN (503)
APREMILAST (314)
TREPROSTINIL (295)
EPOPROSTENOL (205)
LENALIDOMIDE (146)
ETANERCEPT (142)
INTERFERON BETA-1A (115)
Which PALBOCICLIB Alternatives Have Lower Product administration interrupted Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID